Global Impact - The importance of the Irish biopharma industry
The report highlights how the pandemic, geopolitical tensions, and heightened international competition are emphasising a renewed focus on competitiveness. The sector has identified policy priorities across four key areas:
- Achieving sustainability goals through strengthening financial, regulatory, and advisory supports.
- Encouraging and resourcing innovation and broadening the ecosystem supported by an “Office of LifeSciences.”
- Meeting skills demand through effective implementation of the recommendations of the Expert Group on Future Skills Needs for BioPharma.
- Remaining competitive through fit-for-purpose regulation.
